
Marie-Claire Seeley, PhD, MNurs, RN, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
Sachin Nagrani, MD, the medical director of Heal, discusses Pfizer’s research assessing an Omicron-specific vaccine for adults aged 18 to 55 years.
Pharmacy Times interviewed Sachin Nagrani, MD, the medical director of Heal, on Pfizer’s research assessing an Omicron-specific vaccine for adults aged 18 to 55 years.
During the interview, Nagrani provided details regarding the Pfizer Omicron-specific vaccine under investigation, when the vaccine may become available to be sent to pharmacies for administration to patients, whether Pfizer is the only company looking to develop a specific variant-targeted vaccine, and whether booster shots that are not variant-specific are still beneficial for patients to pursue.






